{"id":94179,"date":"2022-07-01T06:02:37","date_gmt":"2022-07-01T10:02:37","guid":{"rendered":"https:\/\/www.eldiario.net\/portal\/?p=94179"},"modified":"2022-07-01T06:02:37","modified_gmt":"2022-07-01T10:02:37","slug":"farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid","status":"publish","type":"post","link":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/","title":{"rendered":"Farmac\u00e9utica Pfizer  solicita a EEUU aprobar  tratamiento oral Paxlovid"},"content":{"rendered":"<p>Pfizer Inc inform\u00f3 ayer que solicit\u00f3 la aprobaci\u00f3n en Estados Unidos para el uso generalizado de su tratamiento antiviral oral Paxlovid contra el covid-19, que actualmente est\u00e1 disponible bajo una autorizaci\u00f3n de uso de emergencia, confirm\u00f3 la farmac\u00e9utica.<br \/>\nLa compa\u00f1\u00eda afirm\u00f3 que present\u00f3 una solicitud de nuevo f\u00e1rmaco para Paxlovid ante la Administraci\u00f3n de Alimentos y Medicamentos (FDA) para el tratamiento de covid-19 en personas vacunadas y no vacunadas con alto riesgo de progresi\u00f3n a enfermedad grave.<br \/>\nEl pedido es b\u00e1sicamente consistente con la autorizaci\u00f3n de emergencia actual del medicamento, que seg\u00fan Pfizer cubre entre el 50% y el 60% de la poblaci\u00f3n de Estados Unidos, citando estimaciones de los Centros para el Control y la Prevenci\u00f3n de Enfermedades (CDC). (Reuters)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Inc inform\u00f3 ayer que solicit\u00f3 la aprobaci\u00f3n en Estados Unidos para el uso generalizado de su tratamiento antiviral oral Paxlovid contra el covid-19, que actualmente est\u00e1 disponible bajo una autorizaci\u00f3n de uso de emergencia, confirm\u00f3 la farmac\u00e9utica. La compa\u00f1\u00eda afirm\u00f3 que present\u00f3 una solicitud de nuevo f\u00e1rmaco para Paxlovid ante la Administraci\u00f3n de Alimentos [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-94179","post","type-post","status-publish","format-standard","category-internacional"],"acf":{"antetitulo":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid - El Diario - Bolivia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid - El Diario - Bolivia\" \/>\n<meta property=\"og:description\" content=\"Pfizer Inc inform\u00f3 ayer que solicit\u00f3 la aprobaci\u00f3n en Estados Unidos para el uso generalizado de su tratamiento antiviral oral Paxlovid contra el covid-19, que actualmente est\u00e1 disponible bajo una autorizaci\u00f3n de uso de emergencia, confirm\u00f3 la farmac\u00e9utica. La compa\u00f1\u00eda afirm\u00f3 que present\u00f3 una solicitud de nuevo f\u00e1rmaco para Paxlovid ante la Administraci\u00f3n de Alimentos [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/\" \/>\n<meta property=\"og:site_name\" content=\"El Diario - Bolivia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/eldiario.bolivia\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-01T10:02:37+00:00\" \/>\n<meta name=\"author\" content=\"Jeanette\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@eldiario_net\" \/>\n<meta name=\"twitter:site\" content=\"@eldiario_net\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jeanette\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2022\\\/07\\\/01\\\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2022\\\/07\\\/01\\\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\\\/\"},\"author\":{\"name\":\"Jeanette\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#\\\/schema\\\/person\\\/7f32545115b096f29aabdeed99c3e706\"},\"headline\":\"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid\",\"datePublished\":\"2022-07-01T10:02:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2022\\\/07\\\/01\\\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\\\/\"},\"wordCount\":141,\"publisher\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#organization\"},\"articleSection\":[\"Internacional\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2022\\\/07\\\/01\\\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\\\/\",\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2022\\\/07\\\/01\\\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\\\/\",\"name\":\"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid - El Diario - Bolivia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#website\"},\"datePublished\":\"2022-07-01T10:02:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2022\\\/07\\\/01\\\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2022\\\/07\\\/01\\\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2022\\\/07\\\/01\\\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/\",\"name\":\"El Diario - Decano de la prensa nacional\",\"description\":\"El Diario - Decano de la prensa nacional\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#organization\",\"name\":\"El Diario - Decano de la prensa nacional\",\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/logo_ED.jpg\",\"contentUrl\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/logo_ED.jpg\",\"width\":272,\"height\":52,\"caption\":\"El Diario - Decano de la prensa nacional\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/eldiario.bolivia\\\/\",\"https:\\\/\\\/x.com\\\/eldiario_net\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#\\\/schema\\\/person\\\/7f32545115b096f29aabdeed99c3e706\",\"name\":\"Jeanette\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g\",\"caption\":\"Jeanette\"},\"sameAs\":[\"https:\\\/\\\/www.eldiario.net\\\/portal\"],\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/author\\\/jeanette\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid - El Diario - Bolivia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/","og_locale":"es_ES","og_type":"article","og_title":"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid - El Diario - Bolivia","og_description":"Pfizer Inc inform\u00f3 ayer que solicit\u00f3 la aprobaci\u00f3n en Estados Unidos para el uso generalizado de su tratamiento antiviral oral Paxlovid contra el covid-19, que actualmente est\u00e1 disponible bajo una autorizaci\u00f3n de uso de emergencia, confirm\u00f3 la farmac\u00e9utica. La compa\u00f1\u00eda afirm\u00f3 que present\u00f3 una solicitud de nuevo f\u00e1rmaco para Paxlovid ante la Administraci\u00f3n de Alimentos [&hellip;]","og_url":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/","og_site_name":"El Diario - Bolivia","article_publisher":"https:\/\/www.facebook.com\/eldiario.bolivia\/","article_published_time":"2022-07-01T10:02:37+00:00","author":"Jeanette","twitter_card":"summary_large_image","twitter_creator":"@eldiario_net","twitter_site":"@eldiario_net","twitter_misc":{"Escrito por":"Jeanette","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/#article","isPartOf":{"@id":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/"},"author":{"name":"Jeanette","@id":"https:\/\/www.eldiario.net\/portal\/#\/schema\/person\/7f32545115b096f29aabdeed99c3e706"},"headline":"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid","datePublished":"2022-07-01T10:02:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/"},"wordCount":141,"publisher":{"@id":"https:\/\/www.eldiario.net\/portal\/#organization"},"articleSection":["Internacional"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/","url":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/","name":"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid - El Diario - Bolivia","isPartOf":{"@id":"https:\/\/www.eldiario.net\/portal\/#website"},"datePublished":"2022-07-01T10:02:37+00:00","breadcrumb":{"@id":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.eldiario.net\/portal\/2022\/07\/01\/farmaceutica-pfizer-solicita-a-eeuu-aprobar-tratamiento-oral-paxlovid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.eldiario.net\/portal\/"},{"@type":"ListItem","position":2,"name":"Farmac\u00e9utica Pfizer solicita a EEUU aprobar tratamiento oral Paxlovid"}]},{"@type":"WebSite","@id":"https:\/\/www.eldiario.net\/portal\/#website","url":"https:\/\/www.eldiario.net\/portal\/","name":"El Diario - Decano de la prensa nacional","description":"El Diario - Decano de la prensa nacional","publisher":{"@id":"https:\/\/www.eldiario.net\/portal\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eldiario.net\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.eldiario.net\/portal\/#organization","name":"El Diario - Decano de la prensa nacional","url":"https:\/\/www.eldiario.net\/portal\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.eldiario.net\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/www.eldiario.net\/portal\/wp-content\/uploads\/2023\/07\/logo_ED.jpg","contentUrl":"https:\/\/www.eldiario.net\/portal\/wp-content\/uploads\/2023\/07\/logo_ED.jpg","width":272,"height":52,"caption":"El Diario - Decano de la prensa nacional"},"image":{"@id":"https:\/\/www.eldiario.net\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/eldiario.bolivia\/","https:\/\/x.com\/eldiario_net"]},{"@type":"Person","@id":"https:\/\/www.eldiario.net\/portal\/#\/schema\/person\/7f32545115b096f29aabdeed99c3e706","name":"Jeanette","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g","caption":"Jeanette"},"sameAs":["https:\/\/www.eldiario.net\/portal"],"url":"https:\/\/www.eldiario.net\/portal\/author\/jeanette\/"}]}},"_links":{"self":[{"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/posts\/94179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/comments?post=94179"}],"version-history":[{"count":0,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/posts\/94179\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/media?parent=94179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/categories?post=94179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/tags?post=94179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}